admin October 12th, 2007
October 12, 2007
Drugstores across Kentucky are pulling 14 defective products from their shelves because of a Food and Drug Adminstration recall covering several over-the-counter cough and cold medicines for infants, according to Courier-Journal.
The nationwide recall came one week before the FDA’s plans for a hearing on nonprescription cough and cold medications for children, slated for Oct. 18-19. The hearing is intended to discover whether the medicines are ineffective and dangerous in light of increasing evidence of serious drug injuries and complications, which may be fatal in some cases.
McNeil Consumer Healthcare, Novartis Consumer Health Inc., and Wyeth Inc., are the pharmaceutical giants responsible for making these drugs that are involved in the recall and make up at least 95 percent of the market, according to the FDA.
Read More:
http://www.courier-journal.com/apps/pbcs.dll/article?AID=/20071012/NEWS01/71012001/1008
Popularity: 64% [?]
admin October 5th, 2007
October 5, 2007
Officials in eastern Kentucky filed a class-action lawsuit against OxyContin-manufacturing giant, Purdue Pharma, according to the Louisville Courier-Journal. They are demanding millions in compensation for the costs of drug abuse programs, law enforcement, and prescription payments through Medicaid and the Kentucky Pharmaceutical Assistance program.
The mountains of Appalachia is an area stricken with drug problems, and the leaders claim the drugs produced by Purdue Pharma substantially contribute to the problem and cause Kentucky drug injuries. OxyContin, the brand name of oxycodone, has been blamed for hundreds of Kentucky drug injuries and deaths in recent years. In Appalachian states like Kentucky, Virginia, and West Virginia, the drug has been labeled “hillbilly heroin.”
Although Purdue Pharma officials said the current OxyContin packaging adequately warns against the dangers of abusing the drug, Kentucky officials decided to pursue the drug injury lawsuit after the company pleaded guilty to misleading the public about the risk of addiction associated with the drug earlier this year.
Read More:
[http://www.courier-journal.com/apps/pbcs.dll/article?AID=/20071004/NEWS01/71004022]
Popularity: 32% [?]
